The next frontier: Global leadership in biopharma
Express Pharma
JULY 10, 2024
India has traced a journey of grit and glory to emerge as a major supplier of generic drugs and vaccines globally. Brimming with potential As per an Invest India report of 2023, the Indian Bioeconomy, valued at $137 billion in 2023, is targeted to reach $150 billion by 2025 and $300 billion by 2030. million and contributes around $1.4
80 
Let's personalize your content